Sanofi teams up with Google
01.09.2015 - Sanofi is partnering up with Google’s life sciences team with an ambitious goal: to change the face of diabetes management.
The two companies, each leading in their respective fields, plan to transform type 1 and type 2 diabetes care. They aim to find better ways to collect, analyse and understand multiple sources of information impacting diabetes. Paris-based Sanofi, a longstanding leader in diabetes care, is pairing its expertise with Google’s know-how in analytics, miniturised electronics and low power chip design.
The tools to be developed are meant to bring previously siloed solutions together. They also strive to enable new kinds of interventions, including health indicators such as blood glucose and hemoglobin A1c levels, patient-reported information, medication regimens and sensor devices. The hope is that it will be easier for patients to successfully manage their diabetes, which would reduce the risk of complications, improve outcomes and ultimately lower costs. “With new technologies emerging to provide a more continuous and real-time view of a patient's health, we can see the promise for more proactive and effective ways to control diabetes,” said Andy Conrad, CEO of the life sciences team at Google.
Sanofi CEO Olivier Brandicourt commented: “This initiative combines Sanofi's strength and knowledge in diabetes with Google's leadership in technology and analytics to create a first-of-its-kind initiative with the potential to transform diabetes care.” John L. Brooks, III, President and CEO of the Joslin Diabetes Center, which is a partner to the collaboration, expressed hopes that “technology, sensors, analytics, and digital solutions will revolutionise how blood sugars are managed, which will deliver improved quality of life, lowering the risk of complications and reducing the costs and barriers associated with diabetes care.” Brooks added: “Ultimately, I truly hope we're able to turn the Joslin Diabetes Center into a museum.”